LIEBERMAN GERALD M
SEC CIK 1234346 · EDGAR
BoughtSold
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
| 20 | LIEBERMAN GERALD M | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:04 | 2026-06-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | LIEBERMAN GERALD M | Dir | M - OptEx | — | +14.5K | 130.1K | +13% | — |
| D | 2026-01-02 | 2026-01-01 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | A - Grant | $0.00 | +38.3K | 338.5K | +13% | $0 |
| D | 2025-06-09 | 2025-06-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | LIEBERMAN GERALD M | Dir | M - OptEx | — | +9,632 | 115.7K | +9% | — |
| D | 2025-04-03 | 2025-04-01 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | M - OptEx | $1.00 | +24.0K | 300.2K | +9% | +$24.0K |
| D | 2025-01-17 | 2025-01-15 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | A - Grant | $0.00 | +10.7K | 276.2K | +4% | $0 |
| 2024-10-04 | 2024-10-02 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | A - Grant | $0.00 | +11.3K | 265.5K | +4% | $0 | |
| 2024-08-29 | 2024-08-27 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | A - Grant | $0.00 | +27.3K | 254.2K | +12% | $0 | |
| D | 2024-06-17 | 2024-06-15 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | LIEBERMAN GERALD M | Dir | M - OptEx | — | +21.1K | 106.0K | +25% | — |
| D | 2023-12-27 | 2023-12-22 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $0.71 | +24.0K | 227.0K | +12% | +$17.0K |
| 2023-08-23 | 2023-08-21 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $0.59 | +20.0K | 214.2K | +10% | +$11.8K | |
| D | 2023-08-07 | 2023-08-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | LIEBERMAN GERALD M | Dir | M - OptEx | — | +15.8K | 84.9K | +23% | — |
| MI | 2022-11-15 | 2022-11-14 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $0.5675 | +16.0K | 6,200 | New | +$9,080 |
| 2022-11-15 | 2022-11-14 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $0.57 | +34.0K | 194.2K | +21% | +$19.4K | |
| 2022-07-25 | 2022-07-21 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $1.68 | +19.5K | 160.2K | +14% | +$32.7K | |
| D | 2022-06-16 | 2022-06-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | LIEBERMAN GERALD M | Dir | M - OptEx | — | +14.5K | 69.1K | +27% | — |
| MI | 2022-01-24 | 2022-01-18 | ENTX | Entera Bio Ltd. | LIEBERMAN GERALD M | Dir | P - Purchase | $2.80 | +2,800 | 2,200 | New | +$7,840 |
Purchase Sale Sale after option exercise All abbreviations